These data confirm the debilitating effects of apathy on functioning in patients with Huntington disease.
The authors noted that apathy is very common and progressive among Huntington disease mutation carriers, even during early stages of the disease, and has been associated with decline in general functioning.
Electrical stimulation of the amygdala may boost declarative memory without influencing an emotional response.
The HD-associated CAG repeat with 36 or more repeats was found in 18 individuals.
The FDA has accepted Teva's New Drug Application for deutetrabenazine to treat chorea associated with Huntington's disease.
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Impulsivity in Bipolar Disorder, Borderline Personality Disorder, ADHD
- The Challenges of Identifying Biomarkers of Psychiatric Illness
- Cardioprotective Treatment May Reduce Adverse Effects in Schizophrenia
- Oral Therapy for Suicidal Bipolar Depression Gets Breakthrough Designation
- FDA Approves Powerful New Opioid Despite Criticisms
- Cannabis Use in Adolescence Associated With Poorer Mental Health Outcomes
- Updates in Borderline Personality Disorder: Your Questions Answered
- Violent Video Games Tied to Physical Aggression
- Shame Drives Suicidal Ideation Among Veterans With PTSD
- Long-term Healthy Diet Associated With Greater Hippocampal Volumes
- Perseris Now Available for the Treatment of Schizophrenia in Adults
- Noninvasive Brain Stimulation of Prefrontal Cortex in Trait Anxiety
- Peer Support Reduces Hospitalizations in People With Diabetes and Depression
- FDA to Ban Most Flavored Electronic Cigarettes
- Predictors of CBT Outcomes Identified in Youths With Anxiety Disorders